Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-05-20

FDA Approved: EDURANT — Original Application (Janssen Products, LP)

View source ↗

Summary

The FDA approved the original application for Edurant (rilpivirine hydrochloride) from Janssen, introducing this HIV-1 antiretroviral agent to the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Edurant (rilpivirine)

Snippet

ORIG AP for EDURANT (RILPIVIRINE HYDROCHLORIDE)